164 related articles for article (PubMed ID: 24726633)
21. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
22. Development of multiple-layer polymeric particles for targeted and controlled drug delivery.
Koppolu B; Rahimi M; Nattama S; Wadajkar A; Nguyen KT
Nanomedicine; 2010 Apr; 6(2):355-61. PubMed ID: 19699325
[TBL] [Abstract][Full Text] [Related]
23. Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.
Graves RA; Ledet GA; Glotser EY; Mitchner DM; Bostanian LA; Mandal TK
Eur J Pharm Sci; 2015 Aug; 76():1-9. PubMed ID: 25933716
[TBL] [Abstract][Full Text] [Related]
24. Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery system.
Kona S; Dong JF; Liu Y; Tan J; Nguyen KT
Int J Pharm; 2012 Feb; 423(2):516-24. PubMed ID: 22172292
[TBL] [Abstract][Full Text] [Related]
25. Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer.
Lee WK; Park JY; Yang EH; Suh H; Kim SH; Chung DS; Choi K; Yang CW; Park JS
J Control Release; 2002 Dec; 84(3):115-23. PubMed ID: 12468215
[TBL] [Abstract][Full Text] [Related]
26. Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system.
Sweet JL; Pillay V; Choonara YE
Drug Deliv; 2007 Jul; 14(5):309-18. PubMed ID: 17613019
[TBL] [Abstract][Full Text] [Related]
27. Designing bioresorbable polyester matrices for controlled doxorubicin release in glioma therapy.
Kasperczyk J; Stoklosa K; Dobrzynski P; Stepien K; Kaczmarczyk B; Dzierzega-Lecznar A
Int J Pharm; 2009 Dec; 382(1-2):124-9. PubMed ID: 19715746
[TBL] [Abstract][Full Text] [Related]
28. Molecular weight distribution changes during degradation and release of PLGA nanoparticles containing epirubicin HCl.
Birnbaum DT; Brannon-Peppas L
J Biomater Sci Polym Ed; 2003; 14(1):87-102. PubMed ID: 12635772
[TBL] [Abstract][Full Text] [Related]
29. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
30. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles.
Panyam J; Sahoo SK; Prabha S; Bargar T; Labhasetwar V
Int J Pharm; 2003 Aug; 262(1-2):1-11. PubMed ID: 12927382
[TBL] [Abstract][Full Text] [Related]
31. Formulation and in vitro-in vivo evaluation of black raspberry extract-loaded PLGA/PLA injectable millicylindrical implants for sustained delivery of chemopreventive anthocyanins.
Desai KG; Olsen KF; Mallery SR; Stoner GD; Schwendeman SP
Pharm Res; 2010 Apr; 27(4):628-43. PubMed ID: 20148292
[TBL] [Abstract][Full Text] [Related]
32. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
33. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
[TBL] [Abstract][Full Text] [Related]
34. Nanotechnology for biomaterials engineering: structural characterization of amphiphilic polymeric nanoparticles by 1H NMR spectroscopy.
Hrkach JS; Peracchia MT; Domb A; Lotan N; Langer R
Biomaterials; 1997 Jan; 18(1):27-30. PubMed ID: 9003893
[TBL] [Abstract][Full Text] [Related]
35. PLA/PLGA nanoparticles for sustained release of docetaxel.
Musumeci T; Ventura CA; Giannone I; Ruozi B; Montenegro L; Pignatello R; Puglisi G
Int J Pharm; 2006 Nov; 325(1-2):172-9. PubMed ID: 16887303
[TBL] [Abstract][Full Text] [Related]
36. Drug-loaded PLGA nanoparticles for oral administration: fundamental issues and challenges ahead.
Kumar G; Shafiq N; Malhotra S
Crit Rev Ther Drug Carrier Syst; 2012; 29(2):149-82. PubMed ID: 22475089
[TBL] [Abstract][Full Text] [Related]
37. Development of 6-Thioguanine conjugated PLGA nanoparticles through thioester bond formation: Benefits of electrospray mediated drug encapsulation and sustained release in cancer therapeutic applications.
Chatterjee M; Jaiswal N; Hens A; Mahata N; Chanda N
Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111029. PubMed ID: 32994006
[TBL] [Abstract][Full Text] [Related]
38. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.
Avgoustakis K
Curr Drug Deliv; 2004 Oct; 1(4):321-33. PubMed ID: 16305394
[TBL] [Abstract][Full Text] [Related]
39. Spatiotemporal drug delivery using laser-generated-focused ultrasound system.
Di J; Kim J; Hu Q; Jiang X; Gu Z
J Control Release; 2015 Dec; 220(Pt B):592-9. PubMed ID: 26299506
[TBL] [Abstract][Full Text] [Related]
40. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]